The Coherex WaveCrest LAA occlusion system is CE Marked and currently available for commercial use in the applicable countries. Coherex is excited to announce that Biosense Webster, an industry leader in developing treatment options for patients with atrial fibrillation, will be the exclusive distributor of the WaveCrest LAA Occlusion System in markets outside the United States. To learn more about the availability of the WaveCrest device in your country, provide the necessary information below.

[insert_php]get_template_part(‘templates/form’, ‘international’);[/insert_php]

Structural Heart Solutions

Copyright © 2017 Coherex Medical